NADAC

Also known as: National Average Drug Acquisition Cost

The CMS-published actual acquisition cost from a national survey of US pharmacies.

Definition

CMS's National Average Drug Acquisition Cost (NADAC) is a weekly-published, survey-based estimate of what US retail pharmacies actually pay manufacturers/wholesalers per drug unit. NADAC is the closest public proxy for net price and is used to benchmark Medicaid reimbursement.

See also

• WAC — The US list price of a drug — manufacturer to wholesaler, before any discounts or rebates.
• ASP — The weighted average net selling price of a drug to all US purchasers.

Other commercial terms

• Biosimilar
• Generic drug
• QALY
• NICE TA
• ICER (cost)
• WAC